Results 211 to 220 of about 32,366 (248)
Some of the next articles are maybe not open access.
Systemic Juvenile Idiopathic Arthritis: Diagnosis and Management
The Indian Journal of Pediatrics, 2016Systemic juvenile idiopathic arthritis (sJIA) is an inflammatory condition characterized by fever, lymphadenopathy, arthritis, rash and serositis. In sJIA, systemic inflammation has been associated with dysregulation of the innate immune system, suggesting that it is an autoinflammatory disorder.
openaire +2 more sources
Treatment of non-systemic juvenile idiopathic arthritis
Nature Reviews RheumatologyIn the past two decades, the treatment of juvenile idiopathic arthritis (JIA) has evolved markedly, owing to the availability of a growing number of novel, potent and relatively safe therapeutic agents and the shift of management strategies towards early achievement of disease remission.
Susan Shenoi +3 more
openaire +2 more sources
Inflammatory cytokines and systemic-onset juvenile idiopathic arthritis
Modern Rheumatology, 2004Systemic-onset juvenile idiopathic arthritis (JIA) is a severe and steroid-dependent disease, which sometimes progresses to the fatal disease macrophage activation syndrome. An investigation of inflammatory cytokine levels revealed increases in IL-6 in serum of systemic-onset disease patients.
Shumpei, Yokota +5 more
openaire +2 more sources
Systemic onset juvenile idiopathic arthritis-its unusual presentation
The Indian Journal of Pediatrics, 2008We report a case of systemic onset juvenile idiopathic arthritis (SOJIA), the manifestations of which started with fever and skin rash followed by arthritis within neonatal age. Such presentation is extremely rare in the newborn. After exclusion of closely mimicking conditions like congenital infections, neonatal onset multisystem inflammatory disease (
J B, Ghosh +2 more
openaire +2 more sources
Glucocorticoids in the Management of Systemic Juvenile Idiopathic Arthritis
Pediatric Drugs, 2013Glucocorticoids have been the mainstay of treatment for many years in systemic-onset juvenile idiopathic arthritis (sJIA), causing important side effects and some difficulties in the management of this disease. Until the introduction of biologic agents, oral glucocorticoids were used to control fever and other systemic features for several months or ...
G. Vannucci +7 more
openaire +4 more sources
Systemic juvenile idiopathic arthritis: diagnosis, management, and outcome
Nature Clinical Practice Rheumatology, 2006Systemic juvenile idiopathic arthritis is a heterogeneous form of arthritis in childhood and represents 10-20% of all juvenile idiopathic arthritides in the Caucasian populations of Northern America and Europe. Up to 30% of patients will still have active disease after 10 years, and morbidity within this group is high.
openaire +2 more sources
Systemic onset juvenile idiopathic arthritis
Hariharan U, Garg R: Systemic onset juvenile idiopathic arthritis, 2021Hariharan, Uma, Garg, Rakesh
openaire +1 more source
Etanercept in systemic juvenile idiopathic arthritis.
Clinical and experimental rheumatology, 2003To evaluate the effectiveness of etanercept in patients with systemic juvenile idiopathic arthritis (SJIA) refractory to methotrexate (MTX) therapy in a pediatric rheumatology practice.Fifteen patients with SJIA with active polyarthritis refractory to higher dose MTX (> or = 20 mg/m2/week) for at least 3 months were included.
R A G, Russo, M M, Katsicas, M, Zelazko
openaire +1 more source
Tocilizumab for Systemic Juvenile Idiopathic Arthritis
New England Journal of Medicine, 2013Noboru, Hagino +2 more
openaire +3 more sources
SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS
2011Fabrizio De Benedetti, Rayfel Schneider
openaire +1 more source